For Which Cancer Types Should I Avoid Persimmon Supplement?

Highlights

Nutritional supplements and extracts like Persimmon have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Persimmon supplement and why should not take them?

Is it okay to take Persimmon extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.

A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.

To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.

Taking Persimmon extracts or nutritional supplements may benefit Primary Sinonasal Undifferentiated Carcinoma patients on Radiation treatment over Barberry nutritional supplements. But Persimmon supplements or Persimmon extracts offer less benefit if on Radiation treatment for Primary Urethral Squamous Cell Carcinoma compared to Sangre De Grado. Similarly, taking nutritional supplements Persimmon may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene JAK2 over Amentoflavone. But avoid nutritional supplements Persimmon when at genetic risk of cancer due to mutation of gene MYC.

The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Persimmon beneficial and should not be taken? Why should Persimmon be not taken? Who should not take Persimmon? What are side effects of Persimmon with Radiation chemotherapy? What are the benefits of Persimmon for cancer? Can Persimmon help fight cancer and so on.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

Brief Overview

Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.

These are some example questions which nutrition planning should help answer for you. Should you take supplements Persimmon? Should you take it when at genetic risk of cancer for mutation of gene JAK2? Should you take it when at genetic risk of cancer for mutation of gene MYC? Should you take it when diagnosed with Primary Urethral Squamous Cell Carcinoma? Should you take it when diagnosed with Primary Sinonasal Undifferentiated Carcinoma? Should you take it when on Radiation treatment? Should you continue taking it if you change your treatment from Radiation to Radiation? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Persimmon extracts and nutritional supplements.

Cancer

Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Sinonasal Undifferentiated Carcinoma or Primary Urethral Squamous Cell Carcinoma, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Persimmon.

So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Persimmon extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene JAK2 the same as due to mutation of gene MYC? Are the implications of Primary Sinonasal Undifferentiated Carcinoma the same as Primary Urethral Squamous Cell Carcinoma? Is it one and the same if you are on treatment with Radiation or Radiation?

Persimmon – An Extract or Nutritional Supplement

Persimmon is a delicious, globular, orange colored fruit with strong antioxidant properties, and native to China, Northeast India and Northern Indochina. Persimmon fruits are usually low in calories and high in fiber. Being packed with powerful antioxidants like vitamins, minerals and fiber, persimmon intake may :

• Help in optimizing eye health
• Help in boosting immunity
• Help in reducing the risk of diseases like stroke and cardiovascular diseases
• help in reducing inflammation
• Help in managing diabetes

Persimmon supplements contain many active ingredients including Vitamin A, Vitamin C, Lycopene, L-leucine and D-aspartic Acid at different concentration levels. The molecular pathways which are regulated by Persimmon include Hypoxia, RAS-RAF Signaling, Cell Cycle and IL27 Signaling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Persimmon individually or in combination is an important decision to be made. When making decisions on the use of supplement Persimmon over other nutritional supplements – do consider all these factors.

Who Should not take Persimmon Supplements and Why?

There is no easy way to answer the question “For which cancers should I not choosePersimmon nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Persimmon in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Persimmon should be avoided or not and why.

1. Will Persimmon Supplements benefit Primary Urethral Squamous Cell Carcinoma patients undergoing Radiation treatment?

Primary Urethral Squamous Cell Carcinoma is characterized and driven by specific genetic mutations like BLM, BRCA1 and CTCF leading to biochemical pathway changes in RAS-RAF Signaling, Androgen Signaling and DNA Repair. A cancer treatment like Radiation works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Persimmon supplement should not be taken for Primary Urethral Squamous Cell Carcinoma along with treatment Radiation. Persimmon supplement impacts the biochemical pathway called RAS-RAF Signaling which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any

2. Will Persimmon Supplements benefit Primary Sinonasal Undifferentiated Carcinoma Patients undergoing Radiation Treatment?

Primary Sinonasal Undifferentiated Carcinoma is characterized and driven by specific genetic mutations like GATA1, POLE and ASXL1 leading to biochemical pathway changes in Hypoxia, Chromatin Remodeling, DNA Repair, Oncogenic Cancer Epigenetics and Suppressive Histone Methylation. A cancer treatment like Radiation works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Persimmon supplements should be considered for Primary Sinonasal Undifferentiated Carcinoma along with the treatment Radiation. Persimmon supplement impacts pathways/processes like Hypoxia which either obstruct drivers of Primary Sinonasal Undifferentiated Carcinoma and/or improve Radiation treatment effect.

3. What about Persimmon Supplements for Healthy Individuals with MYC Mutation associated Genetic Risk?

Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. MYC is one of the genes generally available in panels for cancer risk testing.

MYC mutation causes biochemical pathways/processes like Cell Cycle, Antigen Presentation, PI3K-AKT-MTOR Signaling and Amino Acid Metabolism to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Persimmon should not be taken when the genetic panel identifies mutation of MYC for Burkitt Lymphoma. Persimmon impacts pathways/processes like Cell Cycle and creates adverse conditions with MYC.

4. What about Persimmon Supplements for Healthy Individuals with JAK2 Mutation associated Genetic Risk?

JAK2 is one of the genes available in panels for cancer risk testing. JAK2 mutation causes biochemical pathways/processes like IL27 Signaling, Cytokine Signaling, JAK-STAT Signaling and Immune Checkpoints to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Persimmon supplements may be considered when the genetic panel identifies mutations in JAK2 for Myeloproliferative Neoplasms. Persimmon impacts pathways/processes like IL27 Signaling and creates a canceling effect in those individuals with JAK2 mutation.

* Other Factors are also included like BMI, Treatments, Lifestyle Habits

In Conclusion

It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Persimmon are chosen by you and can influence outcomes.

“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.

The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.

What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.

The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.

Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.

References

• Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.
• Lycopene Enriched Tomato Extract Inhibits Hypoxia, Angiogenesis, and Metastatic Markers in early Stage N-Nitrosodiethylamine Induced Hepatocellular Carcinoma.
• Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.
• Significance of HIF-1-active cells in angiogenesis and radioresistance.
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
• Lycopene Protects Keratinocytes Against UVB Radiation-Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway.
• cBioPortal for Cancer Genomics